BENEFITS OF USING FERRIC CARBOXIMALTOSE IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA
Introduction: Hereditary hemorrhagic telangiectasia (HHT) is a vascular disorder inherited in an autosomal dominant manner, with a prevalence of 1 patient per 5000-8000 people, approximately affecting 800 people in Uruguay. The Curacao criteria for diagnosis are a family history of HHT, epistaxis, c...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2024-10-01
|
| סדרה: | Hematology, Transfusion and Cell Therapy |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2531137924017279 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|